Two Sigma Advisers
VCYT icon

Two Sigma Advisers’s Veracyte VCYT Stock Holding History

Two Sigma Advisers’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,600
Closed -$459K – 2593
2024
Q4 		$459K Sell
11,600
-3,700
-24% -$140K ﹤0.01% 1804
2024
Q3 		$521K Sell
15,300
-5,100
-25% -$143K ﹤0.01% 1683
2024
Q2 		$442K Buy
20,400
+900
+5% +$18.9K ﹤0.01% 1930
2024
Q1 		$432K Sell
19,500
-600
-3% -$14.6K ﹤0.01% 1935
2023
Q4 		$553K Sell
20,100
-300
-1% -$7.24K ﹤0.01% 1879
2023
Q3 		$456K Sell
20,400
-1,200
-6% -$30.9K ﹤0.01% 1825
2023
Q2 		$550K Buy
21,600
+3,400
+19% +$82.4K ﹤0.01% 1775
2023
Q1 		$406K Buy
18,200
+1,200
+7% +$29K ﹤0.01% 2020
2022
Q4 		$403K Buy
17,000
+300
+2% +$6.97K ﹤0.01% 1962
2022
Q3 		$277K Buy
16,700
+200
+1% +$4.5K ﹤0.01% 2075
2022
Q2 		$328K Buy
16,500
+5,300
+47% +$107K ﹤0.01% 2087
2022
Q1 		$309K Buy
11,200
+1,200
+12% +$34.3K ﹤0.01% 2211
2021
Q4 		$412K Buy
10,000
+1,600
+19% +$70.7K ﹤0.01% 2005
2021
Q3 		$390K Sell
8,400
-125,600
-94% -$5.48M ﹤0.01% 2013
2021
Q2 		$5.36M Buy
134,000
+101,600
+314% +$4.34M 0.01% 834
2021
Q1 		$1.74M Buy
+32,400
New +$1.87M ﹤0.01% 1338
2020
Q4 		– Sell
-15,100
Closed -$491K – 2604
2020
Q3 		$491K Sell
15,100
-81,400
-84% -$2.59M ﹤0.01% 1825
2020
Q2 		$2.5M Sell
96,500
-21,100
-18% -$526K 0.01% 1092
2020
Q1 		$2.86M Sell
117,600
-114,400
-49% -$2.88M 0.01% 934
2019
Q4 		$6.48M Sell
232,000
-155,600
-40% -$4.03M 0.02% 741
2019
Q3 		$9.3M Sell
387,600
-20,700
-5% -$551K 0.02% 566
2019
Q2 		$11.6M Buy
408,300
+147,500
+57% +$3.68M 0.03% 545
2019
Q1 		$6.53M Buy
260,800
+141,200
+118% +$2.7M 0.02% 757
2018
Q4 		$1.5M Buy
119,600
+45,500
+61% +$538K ﹤0.01% 1310
2018
Q3 		$708K Buy
74,100
+50,500
+214% +$557K ﹤0.01% 1655
2018
Q2 		$220K Buy
+23,600
New +$166K ﹤0.01% 2188

Other funds holding VCYT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Two Sigma Advisers's VCYT Position: Q1 2025 in Review

Two Sigma Advisers sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 11,600 shares — an estimated $459K sold.

Two Sigma Advisers first reported a position in VCYT in Q2 2018 and held it in 26 quarters. The position peaked at $11.6M in Q2 2019. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

  • Two Sigma Advisers reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 11,600 Veracyte shares in Q1 2025, an estimated $459K.
  • Two Sigma Advisers first reported a position in Veracyte in Q2 2018 and held it in 26 quarters.
  • Two Sigma Advisers's Veracyte position peaked at $11.6M in Q2 2019.
  • 287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.